1. Home
  2. CRK vs CRSP Comparison

CRK vs CRSP Comparison

Compare CRK & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Resources Inc.

CRK

Comstock Resources Inc.

HOLD

Current Price

$14.20

Market Cap

5.1B

Sector

Energy

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$56.05

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRK
CRSP
Founded
1983
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
4.9B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
CRK
CRSP
Price
$14.20
$56.05
Analyst Decision
Hold
Buy
Analyst Count
10
17
Target Price
$22.20
$70.29
AVG Volume (30 Days)
2.5M
1.6M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
288.16
N/A
EPS
0.38
N/A
Revenue
$555,231,000.00
$289,590,000.00
Revenue This Year
N/A
$807.72
Revenue Next Year
$23.91
$172.52
P/E Ratio
$37.61
N/A
Revenue Growth
32.11
9169.85
52 Week Low
$12.44
$44.12
52 Week High
$28.10
$78.48

Technical Indicators

Market Signals
Indicator
CRK
CRSP
Relative Strength Index (RSI) 54.32 59.03
Support Level $14.16 $50.17
Resistance Level $15.22 $56.16
Average True Range (ATR) 0.54 2.74
MACD 0.24 0.35
Stochastic Oscillator 84.20 76.27

Price Performance

Historical Comparison
CRK
CRSP

About CRK Comstock Resources Inc.

Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. The company's oil and gas operations are concentrated in Louisiana and Texas.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: